Trial Details
Not RecruitingBasic Information
| Clinical ID | c2408 |
|---|---|
| Identifier | EUCTR2020-004012-10-BE |
| Trial Title | Model-informed infliximab dose de-escalation following earlier dose escalation in adult patients with inflammatory bowel diseases - MODIFI |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel diseases_- Crohn's disease_- ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Inflectra Product Name: infliximab Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: INFLIXIMAB CAS Number: 170277-31-3 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- |
Participant Information
| Sponsor | UZ Leuven |
|---|---|
| City | - |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |